Longboard Pharmaceuticals, Inc.

NASDAQ
LBPH
paper.types.company
Rentabilidade por seis meses: 0%
Rendimento de dividendos: 0%
Setor: Healthcare

59.98 $

0 $ 0%
27.58 $
59.98 $

paper.min_max_per_year

Cronograma de promoção Longboard Pharmaceuticals, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

Parâmetros básicos

IPO date
2021-03-12
ISIN
US54300N1037
Industry
Biotechnology
Sector
Health Care
Валюта
usd
Валюта отчета
usd
Сайт
link
Todos os parâmetros

Nota

Subestimação
Nome Significado Nota
P/S 0 0
P/BV 3.44 5
P/E 0 0
Eficiência
Nome Significado Nota
ROA -107.35 0
ROE -132.99 0
ROIC 0 0
Dividendos
Nome Significado Nota
Rendimento de dividendos 0 0
DSI 0 0
Crescimento médio dos dividendos 0 0
Obrigação
Nome Significado Nota
Debt/EBITDA -0.0084 10
Debt/Ratio 0.0094 10
Debt/Equity 0.2388 10
Impulso de crescimento
Nome Significado Nota
Receita, % 0 0
Ebitda, % 294.13 10
EPS, % 181.33 10
Mais detalhes

paper.price.prices

Preço Common.min. Common.max. Mudar paper.changes_in_industry paper.changes_in_index
common.calendar.number_days.1 59.98 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.7d 59.98 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.30d 59.98 $ 0 $ 0 $ 0 % 0 % 0 %
common.calendar.number_days.90d 59.98 $ 59.98 $ 59.98 $ 0 % 0 % 0 %
common.calendar.number_days.180d 59.98 $ 59.98 $ 59.98 $ 0 % 0 % 0 %
common.calendar.number_days.1y 35.2 $ 27.58 $ 59.98 $ +70.4 % 0 % 0 %
common.calendar.number_days.3y 3.65 $ 2.95 $ 59.98 $ +1 543.29 % 0 % 0 %
common.calendar.number_days.5y 2.95 $ 2.95 $ 59.98 $ +2 033.22 % 0 % 0 %
common.calendar.number_days.10y 2.95 $ 2.95 $ 59.98 $ +2 033.22 % 0 % 0 %
common.calendar.number_days.ytd 59.98 $ 59.98 $ 59.98 $ 0 % 0 % 0 %

Principais proprietários

Contido em ETF

ETF
Compartilhar, %
Rentabilidade para o ano, %
Comissão, %
iShares Morningstar Small-Cap Value ETF 0.02069 175.74 0.06
iShares Morningstar Small-Cap ETF 0.01851 301.34 0.25
iShares Morningstar Small-Cap Growth ETF 0.01676 570.49 0.06
0,02349,190,12

Empresas semelhantes

P/E & P/BVEV/Ebitda & Debt/Ebitda


Gestão da empresa

Supervisor Cargo Pagamento Ano de nascimento
Mr. Kevin R. Lind President, CEO, Secretary & Director 1.07M 1976 (49 anos)
Ms. Brandi L. Roberts CPA, M.B.A. Executive VP & CFO 662.65k 1974 (51 ano)
Dr. Randall E. Kaye M.D. Executive VP & Chief Medical Officer 717.95k 1962 (63 ano)
Mr. Chadwick J. Orevillo MPH Executive VP & Head of Operations N/A
Mr. Steven W. Spector J.D. Executive VP, Head of Business Development & General Counsel N/A 1965 (60 anos)
Dr. Anne M. Danks Ph.D. VP & Head of Nonclinical Research & Development N/A
Mr. Gus Cardenas VP & Head of Quality Assurance N/A
Dr. Marco Peters Ph.D. VP & Head of Translational Science N/A
Dr. Dewey McLin Ph.D. VP & Head of Medical Affairs N/A
Ms. Megan E. Knight VP & Head of Investor Relations

Informações da empresa

Endereço: United States, La Jolla. CA, 4275 Executive Square - Abrir no google maps, Abrir mapas yandex
Site: https://www.longboardpharma.com

Sobre a empresa Longboard Pharmaceuticals, Inc.

Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing novel and transformative medicines for neurological diseases. Its lead product candidate is LP352, which is in Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. The company's preclinical product candidate includes LP659 which focuses on developing therapies for multiple neurological diseases; and LP143. It also entered into license agreement with Arena Pharmaceuticals Inc. to develop and commercialize LP352, LP659, LP143, and other compounds. The company was formerly known as Arena Neuroscience, Inc. and changed its name to Longboard Pharmaceuticals, Inc. in October 2020. Longboard Pharmaceuticals, Inc. was incorporated in 2020 and is based in La Jolla, California.